KR860000282A - 항 세균성을 갖는 화합물의 제조방법 - Google Patents

항 세균성을 갖는 화합물의 제조방법 Download PDF

Info

Publication number
KR860000282A
KR860000282A KR1019850003890A KR850003890A KR860000282A KR 860000282 A KR860000282 A KR 860000282A KR 1019850003890 A KR1019850003890 A KR 1019850003890A KR 850003890 A KR850003890 A KR 850003890A KR 860000282 A KR860000282 A KR 860000282A
Authority
KR
South Korea
Prior art keywords
compound
alkyl
group
alkoxy
general formula
Prior art date
Application number
KR1019850003890A
Other languages
English (en)
Other versions
KR870000286B1 (ko
Inventor
빌라니 플라비오 (외 1)
Original Assignee
파올로 키에시
키에시 파르마세우티시 에스. 피. 에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파올로 키에시, 키에시 파르마세우티시 에스. 피. 에이 filed Critical 파올로 키에시
Publication of KR860000282A publication Critical patent/KR860000282A/ko
Application granted granted Critical
Publication of KR870000286B1 publication Critical patent/KR870000286B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

내용 없음

Description

항 세균성을 갖는 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 하기 반응식으로 일반식(Ⅱ)의 디에스테를를 화합물(Ⅲ)으로 고리화시키고, 니트로기를 아미노기로 환원시킨 후 〔화합물(Ⅳ)〕, 이 화합물을 산수용체로서의 제3급 염기존재하에 일반식〔R1'-N-(CH2CH2OH)2〕(식중 R1'는 CH3또는 벤질옥시카르보닐기임)의 N-치환디에탄올아민염과 반응시켜서, 얻어진 화합물(Ⅴ)을 염기존재하에, 일킬할로겐화물, 황산염 또는 토실레이트를 사용하여 1위치에서 알킬화시킨 후,
    [상기 식중, R는 알콕시알킬, 알카노일옥시알킬, 아로일옥시알킬, 알콕시카르보닐옥시알킬, 알콕시카르보닐, 아랄킬옥시카르보닐기 또는 일 또는 이 헤테로시클릭기(이 기는 C1-C4알킬에 의해 임의로 치환되고 옥소기를 갖음)이되, 상기 알킬, 알콜시 및 알카노일기들은 직쇄 또는 측쇄이고, 탄소원자가 1내지 5개이고, R1'는 상기 정의한 바와 같음] 얻어진 화합물(Ⅰa)중 R1'가 벤질옥시카르보닐기인 화합물을 수소첨가 분해반응에 의해 이에 대응하는 화합물(Ⅰ)(여기에서,R1'는 수소임)로 전환시키고, 이 화합물을 공지의 방법으로 알킬화시켜서, R1'가 저급알킬인 화합물(Ⅰ)을 얻음을 특징으로 하는 하기 일반식(Ⅰ)으로 표시되는 화합물의 제조방법.
    (식중,R는 상기 정의한 바와 같고, R1'는 H 또는 저급알킬기임).
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019850003890A 1984-06-04 1985-06-04 항세균성을 갖는 화합물의 제조방법 KR870000286B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8421241A IT1213173B (it) 1984-06-04 1984-06-04 Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT21241A/84 1984-06-04

Publications (2)

Publication Number Publication Date
KR860000282A true KR860000282A (ko) 1986-01-27
KR870000286B1 KR870000286B1 (ko) 1987-02-25

Family

ID=11178899

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850003890A KR870000286B1 (ko) 1984-06-04 1985-06-04 항세균성을 갖는 화합물의 제조방법

Country Status (7)

Country Link
KR (1) KR870000286B1 (ko)
BE (1) BE902586A (ko)
CH (1) CH666264A5 (ko)
ES (1) ES8604193A1 (ko)
GB (1) GB2160519B (ko)
IT (1) IT1213173B (ko)
PT (1) PT80590B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
US5286754A (en) * 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
FR2594439B1 (fr) * 1986-02-19 1989-04-21 Vetoquinol Sa Nouveaux derives ester, thioester et amide de quinolone, leur procede de preparation et leur application en therapeutique
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
US5066800A (en) * 1990-04-27 1991-11-19 Hoffmann-La Roche Inc. Qunoline intermediates useful therein for synthesizing antibacterial compounds
ES2050594B1 (es) * 1991-12-31 1994-12-16 Ind Quimica Agropecuaria S A Procedimiento para la obtencion de acidos 6-fluoro-1,4-dihidro-4-oxo-7-piperazino-quinolin-3-carboxilicos sustituidos en 1-n.
ES2048110B1 (es) * 1992-07-22 1995-02-01 Prodesfarma Sa Procedimiento de preparacion de 2,2-dioxidos de pirazino (2,3-c)-1,2,6-tiadiazina n(1) sustituidos.
ES2340500T3 (es) * 2004-06-24 2010-06-04 Bayer Materialscience Ag Composiciones de policarbotanato termoestabilizadas.
CN109942488A (zh) * 2019-04-04 2019-06-28 山东省联合农药工业有限公司 一种喹啉羧酸酯类化合物及其制备方法与用途

Also Published As

Publication number Publication date
GB8513962D0 (en) 1985-07-03
ES543820A0 (es) 1986-01-16
CH666264A5 (it) 1988-07-15
BE902586A (fr) 1985-09-30
ES8604193A1 (es) 1986-01-16
PT80590B (en) 1987-04-21
KR870000286B1 (ko) 1987-02-25
PT80590A (en) 1985-07-01
IT1213173B (it) 1989-12-14
GB2160519A (en) 1985-12-24
IT8421241A0 (it) 1984-06-04
GB2160519B (en) 1988-07-20

Similar Documents

Publication Publication Date Title
KR840001169A (ko) 항비루스성 화합물의 제조방법
KR860001793A (ko) 벤즈 이미다졸 유도체의 제조방법
KR830007643A (ko) 벤조헤테로사이클 화합물의 제조방법
KR840006483A (ko) 항비루스성 화합물의 제조방법
KR830007514A (ko) 두고리 화합물의 제조방법
KR840004406A (ko) 히단토인의 제조방법
KR880007524A (ko) 에리스로마이신 a 유도체 및 그의 제조 방법
KR860000282A (ko) 항 세균성을 갖는 화합물의 제조방법
KR850006938A (ko) 폴루로뮤티린 유도체의 제조방법
KR830007570A (ko) 아자비시클로-옥탄-카복실산의 제조방법
KR840005464A (ko) 포스포리피드 유도체의 제조방법
KR840003260A (ko) [(3-아미노-3-카르복시)-프로필-1]포스핀산 유도체의 제조법
KR860001083A (ko) 신규의 모르포리놀의 제법
KR870006082A (ko) 10β-알키닐에스트렌 유도체의 제조방법
KR850002460A (ko) 카르바메이트 화합물의 제조방법
KR860001795A (ko) 트리아진 유도체의 제조방법
KR850008160A (ko) 이미다졸 유도체의 제조방법
KR830004322A (ko) 항알러지 및 항궤양제 1-옥소-1H-티아졸로 [3,2-a]피리미딘-2-카복사미드와 그의 중간물질
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR830006231A (ko) 벤즈아졸 유도체의 제조방법
KR850005418A (ko) 설포닐구아니딘 유도체의 제조방법
KR840005114A (ko) 아제티딘 술폰산의 제조방법
KR860002486A (ko) 티아진포스폰산 유도체의 제조방법
KR870002118A (ko) 벤질아민 유도체 및 그 제조방법
KR910006223A (ko) 2-알킬아미노-4-아미노벤젤술폰산의 제조방법